OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Programmed Death-1 in Type 1 Diabetes
Christopher Tucker, Alexander J. Dwyer, Brian T. Fife, et al.
Current Diabetes Reports (2021) Vol. 21, Iss. 6
Open Access | Times Cited: 14

Showing 14 citing articles:

The pathogenic “symphony” in type 1 diabetes: A disorder of the immune system, β cells, and exocrine pancreas
Mark A. Atkinson, Raghavendra G. Mirmira
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1500-1518
Open Access | Times Cited: 49

Mechanisms and therapeutic strategies of immune checkpoint molecules and regulators in type 1 diabetes
Jiatong Ding, Kangping Yang, Kong-Lan Lin, et al.
Frontiers in Endocrinology (2023) Vol. 13
Open Access | Times Cited: 14

PD-1 Receptor (+) T cells are associated with the efficacy of the combined treatment with regulatory t cells and rituximab in type 1 diabetes children via regulatory t cells suppressive activity amelioration
Maciej Zieliński, Justyna Sakowska, Dorota Iwaszkiewicz‐Grześ, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111919-111919
Closed Access | Times Cited: 5

Recent advances in immune checkpoint inhibitor-induced type 1 diabetes mellitus
Dehua Liao, Chaoyi Liu, Shanshan Chen, et al.
International Immunopharmacology (2023) Vol. 122, pp. 110414-110414
Open Access | Times Cited: 11

Circulating T Cell Subsets in Type 1 Diabetes
Aldo Ferreira‐Hermosillo, Paola Santana-Sánchez, Ricardo Vaquero-García, et al.
Cells (2025) Vol. 14, Iss. 1, pp. 48-48
Open Access

Chimeric Antigen Receptor (CAR)-Based Cell Therapy for Type 1 Diabetes Mellitus (T1DM); Current Progress and Future Approaches
Vahid Mohammadi, Armin Jahani Maleki, Mahdis Nazari, et al.
Stem Cell Reviews and Reports (2023) Vol. 20, Iss. 3, pp. 585-600
Closed Access | Times Cited: 9

Protective Renalase Deficiency in β-Cells Shapes Immune Metabolism and Function in Autoimmune Diabetes
Kevin Bode, Tara MacDonald, Taylor Stewart, et al.
Diabetes (2023) Vol. 72, Iss. 8, pp. 1127-1143
Open Access | Times Cited: 5

Enhanced T Cell Glucose Uptake Is Associated With Progression of Beta-Cell Function in Type 1 Diabetes
Rong Tang, Ting Zhong, Li Fan, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 5

Programmed cell death-1-modified pig developed using electroporation-mediated gene editing for in vitro fertilized zygotes
Thanh-Van Nguyen, Lanh Thi Kim, Qingyi Lin, et al.
In Vitro Cellular & Developmental Biology - Animal (2024) Vol. 60, Iss. 7, pp. 716-724
Closed Access

Immunometabolic biomarkers for partial remission in type 1 diabetes mellitus
Laia Gómez-Muñoz, Juan Domínguez‐Bendala, Ricardo L. Pastori, et al.
Trends in Endocrinology and Metabolism (2023) Vol. 35, Iss. 2, pp. 151-163
Closed Access | Times Cited: 1

Selective ablation of thymic and peripheral Foxp3+ regulatory T cell development
Açelya Yilmazer, Dimitra Maria Zevla, Rikke Malmkvist, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 1

Selective ablation of thymic and peripheral Foxp3+regulatory T cell development
Açelya Yilmazer, Dimitra Maria Zevla, Rikke Malmkvist, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Type 1 diabetes – What’s new in prevention and therapeutic strategies?
Aleksandra Pilśniak, Ewa Otto-Buczkowska
Pediatric Endocrinology Diabetes and Metabolism (2023) Vol. 29, Iss. 3, pp. 196-201
Open Access

Page 1

Scroll to top